Rolf E. Kuestner
15Patents
7h-index
23Co-inventors
66Inventor score
Filing activity: May 30, 1995 → Jul 16, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7531636B2 | Antibodies to murine zcytor17 ligand | Chemistry; Metallurgy | 50 | Active |
| US7507795B2 | Murine ZCYTOR17 ligand polypeptides | Chemistry; Metallurgy | 42 | Active |
| US7740834B2 | Murine zcytor17 ligand polypeptides | Chemistry; Metallurgy | 38 | Active |
| US7910540B2 | Soluble ZcytoR14, anti-ZcytoR14 antibodies and binding partners and methods of using in inflammation | Chemistry; Metallurgy | 15 | Active |
| US8268773B2 | Methods of treating multiple sclerosis (MS) using an IL-17A and IL-17F antagonist | Chemistry; Metallurgy | 10 | Active |
| US8124378B2 | Murine zcytor17 ligand polynucleotides | Chemistry; Metallurgy | 9 | Active |
| US7622116B2 | Method of treating inflammation using soluble IL-17RCX4 | Chemistry; Metallurgy | 9 | Active |
| US5622839A | Recombinant production of human calcitonin receptor polypeptides | Emerging Cross-Sectional Technologies | 5 | Expired |
| US5683884A | Methods for identifying modulators of human calcitonin mediated metabolism | Emerging Cross-Sectional Technologies | 3 | Expired |
| US6008322A | Stanniocalcin-2 | Human Necessities | 3 | Expired |
| US8093355B2 | Soluble IL-17RCx4 and fusion proteins thereof | Chemistry; Metallurgy | 2 | Active |
| US6171822A | Stanniocalcin-2 | Chemistry; Metallurgy | 2 | Expired |
| US5674689A | Human calcitonin receptor polypeptides and methods of use | Emerging Cross-Sectional Technologies | 1 | Expired |
| US5674981A | Human calcitonin receptor polypeptides | Emerging Cross-Sectional Technologies | 1 | Expired |
| US12252513B2 | Thermostable phycobiliproteins produced from recombinant arthrospira | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.